Calumet Specialty Products Partners LP
NASDAQ:CLMT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.99
22.44
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Calumet Specialty Products Partners LP
Calumet Specialty Products Partners LP stands as a distinctive figure in the oil industry, subtly weaving its presence through the intricate fabric of refining bespoke hydrocarbon products. Unlike the vast majority of its upstream peers focused on commodity fuels, Calumet carves a differentiated path by meticulously refining crude oil into a diverse array of specialty products. These products range from lubricating oils and waxes to hydrocarbon gels and solvents, serving crucial roles in manufacturing, automotive, consumer goods, and even in the production of candles and inks. This specialization not only sets the company apart but also allows it to cater to niche markets where demand is shaped by unique specifications and quality requirements rather than sheer volume and price competition.
The financial model of Calumet pivots on its ability to command premium pricing for these high-margin specialty products. By leveraging its refining expertise, the company effectively transforms raw hydrocarbons into higher-value products that are less subject to the volatility of standard crude oil and fuel markets. Moreover, its strategic focus on investing in research and development enhances its capacity to innovate and tailor solutions for specific customer needs. While it does maintain a footing in the production of ordinary fuels such as gasoline and diesel, its core strength and profitability emerge from its specialty segments. This dual approach provides a balance, enabling the company to capitalize on stable, albeit niche, revenue streams alongside conventional market plays, ensuring resilience against the ever-changing tides of the global oil market.
Calumet Specialty Products Partners LP stands as a distinctive figure in the oil industry, subtly weaving its presence through the intricate fabric of refining bespoke hydrocarbon products. Unlike the vast majority of its upstream peers focused on commodity fuels, Calumet carves a differentiated path by meticulously refining crude oil into a diverse array of specialty products. These products range from lubricating oils and waxes to hydrocarbon gels and solvents, serving crucial roles in manufacturing, automotive, consumer goods, and even in the production of candles and inks. This specialization not only sets the company apart but also allows it to cater to niche markets where demand is shaped by unique specifications and quality requirements rather than sheer volume and price competition.
The financial model of Calumet pivots on its ability to command premium pricing for these high-margin specialty products. By leveraging its refining expertise, the company effectively transforms raw hydrocarbons into higher-value products that are less subject to the volatility of standard crude oil and fuel markets. Moreover, its strategic focus on investing in research and development enhances its capacity to innovate and tailor solutions for specific customer needs. While it does maintain a footing in the production of ordinary fuels such as gasoline and diesel, its core strength and profitability emerge from its specialty segments. This dual approach provides a balance, enabling the company to capitalize on stable, albeit niche, revenue streams alongside conventional market plays, ensuring resilience against the ever-changing tides of the global oil market.
Strong Quarter: Calumet reported $92.5 million of adjusted EBITDA, marking its strongest quarter in years, with record production in Specialty Products & Solutions.
Cost Reductions: Operating costs year-to-date are $60 million lower versus last year, with another $24 million of cost savings delivered in the third quarter alone.
SAF Expansion Progress: Montana Renewables remains on schedule for its MaxSAF expansion in early 2026, having successfully completed a key test run and placed roughly 75% of future SAF volumes under contract or in final review.
Debt Reduction: Over $40 million of restricted group debt was paid down in Q3, and a $320 million reduction in RIN obligations was achieved after favorable small refinery exemption rulings.
PTC Monetization: Calumet completed its first $25 million sale of production tax credits (PTCs) and sold another $15 million in October, with expectations to monetize PTCs more consistently going forward.
Industry Headwinds: Renewable diesel margins industry-wide were pressured by temporarily higher feedstock costs, but management expects normalization and margin recovery in 2026 with regulatory clarity.